Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
30.55
-0.10 (-0.33%)
Feb 11, 2026, 1:35 PM CST
Sinphar Pharmaceutical Revenue
Sinphar Pharmaceutical had revenue of 872.73M TWD in the quarter ending September 30, 2025, with 16.44% growth. This brings the company's revenue in the last twelve months to 3.35B, up 9.88% year-over-year. In the year 2024, Sinphar Pharmaceutical had annual revenue of 3.15B with 6.33% growth.
Revenue (ttm)
3.35B
Revenue Growth
+9.88%
P/S Ratio
1.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.15B | 187.69M | 6.33% |
| Dec 31, 2023 | 2.96B | 106.28M | 3.72% |
| Dec 31, 2022 | 2.86B | 423.14M | 17.39% |
| Dec 31, 2021 | 2.43B | 45.06M | 1.89% |
| Dec 31, 2020 | 2.39B | -6.14M | -0.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Panion & Bf Biotech | 2.04B |
| Savior Lifetec | 1.16B |
| Mycenax Biotech | 649.64M |
| Pharmosa Biopharm | 136.72M |
| OBI Pharma | 49.29M |
| UnicoCell Biomed | 34.58M |
| AnnJi Pharmaceutical | 23.85M |
| Locus Cell | 5.18M |